Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line
- PMID: 2003501
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line
Abstract
The stability of amphotericin B in 5% dextrose injection was studied at concentrations used for administration through a central venous line. Amphotericin B 60, 80, and 100 mg was diluted in 50 mL of 5% dextrose injection; final mean +/- S.D. concentrations after adjustment for total volume were 0.92 +/- 0.01, 1.20 +/- 0.03, and 1.40 +/- 0.03 mg/mL, respectively. For each concentration, six admixtures were prepared; of these, three were stored at 25 degrees C and three at 6 degrees C. Amphotericin B concentration was tested at 0, 4, 12, 24, and 36 hours by stability-indicating high-performance liquid chromatography. The admixtures were inspected visually at each time point for precipitation, turbidity, gas formation, and color change, and the pH was measured. Concentrations of amphotericin B remained within 3% of initial concentrations at each time point at both storage temperatures. No precipitation, turbidity, gas formation, or color change was observed, and no changes in pH were measured. Amphotericin B in 5% dextrose injection was stable at concentrations of 0.92, 1.20, and 1.40 mg/mL when stored at 6 and 25 degrees C for up to 36 hours.
Similar articles
-
Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4 degrees C for 35 days.Am J Hosp Pharm. 1991 Dec;48(12):2635-7. Am J Hosp Pharm. 1991. PMID: 1814207
-
Stability of amphotericin B in four concentrations of dextrose injection.Am J Hosp Pharm. 1991 Nov;48(11):2430-3. Am J Hosp Pharm. 1991. PMID: 1746578
-
Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.Am J Hosp Pharm. 1991 Feb;48(2):280-2. Am J Hosp Pharm. 1991. PMID: 2003500
-
Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.Am J Hosp Pharm. 1991 Jan;48(1):111-3. Am J Hosp Pharm. 1991. PMID: 2000866
-
Practical guidelines for preparing and administering amphotericin B.Am J Hosp Pharm. 1992 May;49(5):1156-64. Am J Hosp Pharm. 1992. PMID: 1595747 Review.
Cited by
-
In search of the amazing technicolour dream coat for amphotericin B.Can J Infect Dis. 1996 Jul;7(4):228-30. doi: 10.1155/1996/802587. Can J Infect Dis. 1996. PMID: 22514442 Free PMC article. No abstract available.
-
Carrier effects on biological activity of amphotericin B.Clin Microbiol Rev. 1996 Oct;9(4):512-31. doi: 10.1128/CMR.9.4.512. Clin Microbiol Rev. 1996. PMID: 8894350 Free PMC article. Review.
-
Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B.Antimicrob Agents Chemother. 1992 Jan;36(1):172-9. doi: 10.1128/AAC.36.1.172. Antimicrob Agents Chemother. 1992. PMID: 1590686 Free PMC article. Clinical Trial.